.gif)
Shri J P Nadda, Union Minister of Health and Family Welfare launched the ‘‘Viral Load testing for all People Living with HIV/AIDS (PLHIV),”at a function.
The initiative will provide free of cost viral load testing for 12 lakh PLHIV on treatment in the country at least once a year. Shri Nadda further announced that after ‘Treat All’, Viral Load test is a big step forward in treating and monitoring people living with HIV. “This Viral Load test is of immense importance to monitor the effectiveness of treatment of patients taking lifelong Antiretroviral Therapy,” he said.Smt. Anupriya Patel, Minister of State for Health & Family Welfare was also present at the launch function.
A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early Age related macular degeneration (AMD).
MSD and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded company focused on oncolytic immunotherapy treatments for a range of cancers by way of a scheme of arrangement (Scheme) for AUD 1.75 cash per Viralytics share. The proposed acquisition values the total issued shares in Viralytics at approximately AUD 502 million (USD 394 million). The cash consideration of AUD 1.75 per share represents a premium of 160% to the one month volume weighted average price (VWAP) of Viralytics shares.
With an aim to boost the medical equipment and devices sector, the State government has signed 25 MoUs. At the summit, a total of 25 MoUs worth Rs 5,090 crore with an employment opportunity of 4,750 jobs pertaining to the health sector were signed.
The European Medicines Agency (EMA) has published that the Committee for Medicinal Products for Human Use (CHMP) and the Committee for Medicinal Products for Veterinary Use (CVMP) – to support the implementation of the so-called 3Rs principles for more ethical use of animals in medicine testing across the European Union (EU).
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation in the European Union (EU) for Amglidia (glibenclamide), a medicine indicated for the treatment of neonatal diabetes mellitus (NDM), for use in newborns, infants and children.
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Also Join: 
.png)
HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.
CSIR-URDIP works in the area of Scientific Informatics (ChemBioinformatics / Patent Informatics / Phytoinformatics / Toxinformatics) and related software development projects. We believe in delivering outstanding knowledge-based services and solutions with high quality and unmatched standards. CSIR-URDIP has a vibrant scientific community consisting of Scientists, Intellectual Property Specialists, Technologists and Project Assistants. The scientific staff are the true strength of CSIR-URDIP. Scientists and Technologists are permanent employees while Project Assistants are hired for a fixed duration depending upon the needs of a particular project. We have an open work culture where talents are honed, achievements recognized, and every contribution is valued.. Hierarchy matters very little when it comes to working relationships at CSIR-URDIP. Senior colleagues provide a nurturing environment and actively mentor freshly recruited scientists and project staff.
